This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This VAPA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 182-210 amino acids from the C-terminal region of human VAPA.
VAPA
Reaktivität: Human
IP
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
VAPA
(VAMP (Vesicle-Associated Membrane Protein)-Associated Protein A, 33kDa (VAPA))
VAP-33 antikoerper, VAP-A antikoerper, VAP33 antikoerper, hVAP-33 antikoerper, 33kDa antikoerper, wu:fa14e12 antikoerper, zgc:65776 antikoerper, zgc:77382 antikoerper, VAMP associated protein A antikoerper, vesicle-associated membrane protein, associated protein A antikoerper, VAMP (vesicle-associated membrane protein)-associated protein A antikoerper, VAPA antikoerper, Vapa antikoerper, vapa antikoerper
Hintergrund
The protein encoded by this gene is a type IV membrane protein. It is present in the plasma membrane and intracellular vesicles. It may also be associated with the cytoskeleton. This protein may function in vesicle trafficking, membrane fusion, protein complex assembly and cell motility. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified.